Proactive Investors
26 Jun 2026, 13:53 UTC · 2h ago
Scancell confirms advanced talks over reverse merger with Neuphoria
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.

Proactive Investors
26 Jun 2026, 13:53 UTC · 2h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.

What the story claims
4 claims · each scored for market impact
Scancell Holdings is in advanced discussions for a reverse merger with US-listed Neuphoria Therapeutics to gain a Nasdaq listing. — A Nasdaq listing significantly increases visibility to US institutional capital and typically improves liquidity and valuation for small-cap biotech firms.
+0.60Scancell is pursuing separate equity and debt financing to fund a global phase III registrational study for its lead drug candidate iSCIB1+. — Phase III trials are the critical final hurdle for regulatory approval; securing funding for this stage is a primary catalyst for biotech value creation.
+0.50EnergyPathways PLC has launched Front End Engineering and Design (FEED) for a potentially world-leading compressed air energy storage project. — Progressing to the FEED stage indicates technical viability and moves the project closer to commercial realization, though it is an early-stage development.
+0.30Continue reading
6 related stories
Search tags
EnergyPathways has secured a £15 million financing package to fund its pre-FEED work with Siemens Energy. — While a positive signal of project viability, the amount is relatively small compared to the total capital typically required for large-scale energy infrastructure.
+0.20Which stocks this story touches
The company has launched FEED for a potentially world-leading energy storage project with confirmed viability and secured financing.
The company is in advanced discussions for a reverse merger to gain a Nasdaq listing and is seeking funding for a Phase III study.
Siemens Energy is mentioned as the partner that confirmed the viability of EnergyPathways' project.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.

WSJ
9h ago